3 unstoppable ASX 200 shares to buy and hold forever

One of the best ways to build your wealth is by investing in ASX 200 shares that can grow strongly over long periods.

But not all shares are capable of doing this. So, let’s take a look at three unstoppable shares that have incredible track records and positive long-term growth outlooks.

They are as follows:

REA Group Ltd (ASX: REA)

REA Group is an unstoppable ASX 200 share that has made investors rich. Over the past 15 years, the realestate.com.au operator’s shares have delivered an average total return of 20.8% per annum.

Its property platforms are embedded in how Australians buy and sell homes. That network effect has been built over decades and is incredibly difficult to replicate.

What drives REA’s compounding is not just property market activity, but its ability to increase revenue per customer. Premium listings, data tools, and value-added services allow the company to grow even when transaction volumes are not booming.

Given its domination of the local market and its growing Indian business, the future looks bright for this ASX share.

ResMed Inc. (ASX: RMD)

Another ASX 200 share that has delivered strong returns for investors is ResMed. It has achieved an average total return of 16.95% per annum since 2016.

This medical device company operates in sleep apnoea and respiratory care, which are areas driven by long-term health trends rather than discretionary spending. Diagnosis rates continue to rise, and once patients are on therapy, they tend to stay there.

What makes ResMed particularly effective at compounding is how it blends hardware with software and data. Devices, masks, cloud platforms, and analytics all work together to create recurring revenue and long-term customer relationships.

Management estimates that the total addressable market for sleep apnoea is over 1 billion people. This gives ResMed a significant growth runway for the next decade and beyond.

TechnologyOne Ltd (ASX: TNE)

Finally, TechnologyOne is a classic example of quiet compounding. Over the past decade, this ASX 200 share has delivered an average total return of 20.2% per annum.

The company provides mission-critical software to governments, universities, and large organisations. These customers do not switch systems lightly, which gives TechnologyOne a sticky client base and highly predictable revenue.

In addition, its shift to a software-as-a-service model has been highly successful and fundamentally changed the business. Revenue visibility has improved, cash generation has strengthened, and recurring income has become a much larger part of the mix.

And with management confident that it can double in size every five years, this ASX share could be destined to outperform long into the future.

The post 3 unstoppable ASX 200 shares to buy and hold forever appeared first on The Motley Fool Australia.

More reading

• ASX Sectors to target and avoid in 2026: Expert
• The best Australian shares to buy in 2026
• A rare buying opportunity in 1 of Australia’s top shares?
• How to make $24,000 in passive income a year
• If a 25-year-old invests $1,250 a month in ASX stocks, here’s what they could have by retirement

Motley Fool contributor James Mickleboro has positions in REA Group, ResMed, and Technology One. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.